Synthesis and evaluation of 1,4-dihydropyridine derivatives with calcium channel blocking activity

Pflugers Archiv European Journal of Physiology

Volumn 466, Issue 7, 2014, Pages 1355-1363

  Bladen, Chris ^a   Gündüz, Miyase Gözde ^b   Şimşek, Rahime ^b   Şafak, Cihat ^b   Zamponi, Gerald W ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

1,4 Dihydropyridine; Aldosterone secretion.; Calcium channels; Cardiovascular; Hypertension; L type; T type

Indexed keywords

1,4 DIHYDROPYRIDINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL T TYPE; CYCLOHEXANE; DIHYDROPYRIDINE; ESTER; 1,4-DIHYDROPYRIDINE; CACNA1H PROTEIN, HUMAN; DIHYDROPYRIDINE DERIVATIVE;

ANGINA PECTORIS; ARTICLE; BINDING AFFINITY; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HYPERTENSION; NONHUMAN; ONE POT SYNTHESIS; PHARMACOPHORE; PRIORITY JOURNAL; ANIMAL; CHEMISTRY; HEK293 CELL LINE; METABOLISM; RAT; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM CHANNELS, T-TYPE; DIHYDROPYRIDINES; HEK293 CELLS; HUMANS; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84904768007     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-013-1376-z     Document Type: Article

References (53)

1. Altier C, Khosravani H, Evans RM, Hameed S, Peloquin JB, Vartian BA, Chen L, Beedle AM, Ferguson SS, Mezghrani A, Dubel SJ, Bourinet E, McRory JE, Zamponi GW (2006) ORL1 receptor-mediated internalization of N-type calcium channels. Nat Neurosci 9:31-40 (Pubitemid 43011907)
2. Arikkath J, Campbell KP (2003) Auxiliary subunits: essential components of the voltage-gated calcium channel complex. Curr Opin Neurobiol 13:298-307 (Pubitemid 36792242)
3. Beedle AM, Hamid J, Zamponi GW (2002) Inhibition of transiently expressed low- and high-voltage-activated calcium channels by trivalent metal cations. J Membr Bio 187:225-238 (Pubitemid 34587778)
4. Bender KJ, Uebele VN, Renger JJ, Trussell LO (2012) Control of firing patterns through modulation of axon initial segment T-type calcium channels. J Physiol 590:109-118
5. 2+ channel antagonist mibefradil (Ro 40-5967). Mol Pharmacol 48(3):540-549
6. Bourinet E, Alloui A, Monteil A, Barrere C, Couette B, Poirot O, Pages A, McRory J, Snutch TP, Eschalier A, Nargeot J (2005) Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. EMBO J 24(2):315-324 (Pubitemid 40216136)
7. Cain SM, Snutch TP (2010) Contributions of T-type calcium channel isoforms to neuronal firing. Channels 4:475-482
8. Carafoli E (2004) Special issue: calcium signaling and disease. Biochem Biophys Res Commun 323:1097
9. Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J (2005) International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev 57(4):411-425 (Pubitemid 43036432)
10. +. Am J Physiol Ren Physiol 276:F674-F683
11. Choi S, Na HS, Kim J, Lee J, Lee S, Kim D, Park J, Chen CC, Campbell KP, Shin HS (2007) Attenuated pain responses in mice lacking Ca(V)3.2 T-type channels. Genes Brain Behav 6(5):425-431 (Pubitemid 47024955)
12. Clapham DE (2007) Calcium signaling. Cell 131:1047-1058 (Pubitemid 350258556)
13. Cohen CJ, Spires S, Van Skiver D (1992) Block of T-Type Ca channels in guinea pig atrial cells by antiarrhythmic agents and Ca channel antagonists. J Gen Physiol 100(4):703-728
14. Cregg R, Momin A, Rugiero F, Wood JN, Zhao J (2010) Pain channelopathies. J Physiol 588(11):1897-1904
15. Cribbs L (2010) T-type calcium channel expression and function in the diseased heart. Channels 4(6):447-452
16. Dolmetsch RE, Lewis RS, Goodnow CC, Healy JI (1997) Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature 386:855-858 (Pubitemid 27181262)
17. Droogmans G, Nilius B (1989) Kinetic properties of the cardiac T-type calcium channel in the guinea-pig. J Physiol 419:627-650 (Pubitemid 20012038)
18. + channels in mammalian central neurons. Trends Neurosci 18:89-98
19. Edraki N, Mehdipour AR, Khoshneviszadeh M, Miri R (2009) Dihydropyridines: evaluation of their current and future pharmacological applications. Drug Discov Today 14:1058-1066
20. Feng ZP, Doering CJ, Winkfein RJ, Beedle AM, Spafford JD, Zamponi GW (2003) Determinants of inhibition of transiently expressed voltage-gated calcium channels by ω-conotoxins GVIA and MVIIA. J Biol Chem 278:20171-20178 (Pubitemid 36799212)
21. Furukawa T, Miura R, Honda M, Kamiya N, Mori Y, Takeshita S, Isshiki T, Nukada T (2004) Identification of R (-)-isomer of efonidipine as a selective blocker of T-type Ca2+ channels. Br J Pharmacol 143:1050-1057 (Pubitemid 40065506)
22. Goldmann S, Stoltefuss J (1991) 1,4-Dihydropyridines - effects of chirality and conformation on the calcium-antagonist and calcium agonist activities. Angew Chem Int Edit 30:1559-1578
23. Gordeev MF, Patel DV, England BP, Jonnalagadda S, Combs JD, Gordon EM (1998) Combinatorial synthesis and screening of a chemical library of 1,4-dihydropyridine calcium channel blockers. Bioorg Med Chem 6:883-889 (Pubitemid 28464518)
24. Heron SE, Khosravani H, Varela D, Bladen C, Williams TC, Newman MR, Ingrid E, Scheffer IE, Berkovic SF, Mulley JC, Zamponi GW (2007) Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants. Ann Neurol 62:560-568
25. Hildebrand ME, Smith PL, Bladen C, Eduljeea C, Xie JY, Chen L, Fee-Maki M, Doering CJ, Mezeyova J, Zhu Y, Belardetti F, Pajouhesh H, Parker D, Arneric SP, Parmar M, Porreca F, Tringham E, Zamponi GW, Snutch TP (2010) A novel slow-inactivation-specific ion channel modulator attenuates neuropathic pain. Pain 152(4):833-843
26. Hockerman GH, Peterson BZ, Sharp E, Tanada TN, Scheuer T, Catterall WA (1997) Molecular determinants of drug binding and action on L-type calciumchannels. Annu Rev Pharmacol Toxicol 37:361-396 (Pubitemid 27238881)
27. Hockerman GH, Peterson BZ, Johnson BD, Catterall WA (1997) Construction of a high-affinity receptor site for dihydropyridine agonists and antagonists by single amino acid substitutions in a non-L-type Ca+channel. Proc Natl Acad Sci 94:14906-14911
28. Houston JB (1994) Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem Pharmacol 9:1469-1479
29. Ioan P, Carosati E, Micucci M, Cruciani G, Broccatelli F, Zhorov BS, Chiarini A, Budriesi R (2011) 1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 1): action in ion channels and GPCRs. Curr Med Chem 18:4901-4922
30. Katz AM, Leach NM (1987) Differential effects of 1,4-dihydropyridine calcium channel blockers: therapeutic implications. J Clin Pharmacol 11:825-834
31. Khosravani H, Zamponi GW (2006) Voltage-gated calcium channels and idiopathic generalized epilepsies. Physiol Rev 86:941-966 (Pubitemid 44033386)
32. Kostyuk PG, Shirokov RE (1989) Deactivation kinetics of different components of calcium inward current in the membrane of mice sensory neurones. J Physiol 409:343-355 (Pubitemid 19052988)
33. Kumar PP, Stotz SC, Paramashivappa R, Beedle AM, Zamponi GW, Srinivasa Rao A (2002) Synthesis and evaluation of a new class of nifedipine analogs with T-Type calcium channel blocking activity. Mol Pharmacol 61:649-658 (Pubitemid 34171931)
34. Lacinová L (2011) T-type calcium channel blockers - new and notable. Gen Physiol Biophys 30(4):403-409
35. Lipkind GM, Fozzard HA (2008)Molecular modeling of interactions of dihydropyridines and phenylalkylamines with the inner pore of the L-type Ca2+ channel. Mol Pharmacol 63:499-511 (Pubitemid 36297319)
36. Miri R, Javidnia K, Sarkarzadeh H, Hemmateenejad B (2006) Synthesis, study of 3D structures, and pharmacological activities of lipophilic nitroimidazolyl-1,4-dihydropyridines as calcium channel antagonist. Bioorg Med Chem 14:4842-4849
37. Nilius B, Talavera K, Verkhratsky A (2006) T-type calcium channels: the never ending story. Cell Calcium 40(2):81-88 (Pubitemid 43942293)
38. Park J, Luo ZD (2010) Calcium channel functions in pain processing. Channels 4(6):510-517
39. Perez-Reyes E (2003) Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev 83:117-161
40. Perez-Reyes E, Van Deusen AL, Vitko I (2009) Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs. JPET 328:621-627
41. Peterson BZ, Catterall WA (1995) Calcium binding in the pore of L-type calcium channels modulates high-affinity dihydropyridine binding. J Biol Chem 270:18201-18204
42. Peterson BZ, Tanada TN, Catterall WA (1996) Molecular determinants of high-affinity dihydropyridine binding in L-type calcium channels. J Biol Chem 271:5293-5296 (Pubitemid 26083856)
43. Peterson BZ, Johnson BD, Hockerman GH, Acheson M, Scheuer T, Catterall WA (1997) Analysis of the dihydropyridine receptor site of L-type calcium channels by alanine-scanning mutagenesis. J Biol Chem 272:18752-18758 (Pubitemid 27318221)
44. Safak C, Ilhan SÖ GMG, Simsek R, Oztürk GS, Isli F, Yildirim S, Oztürk GS, Sarioglu Y, Linden A (2012) Synthesis and myorelaxant activity of fused 1,4-dihydropyridines on isolated rabbit gastric fundus. Drug Dev Res 73:332-342
45. Subramanya AR, Yang CL, McCormick JA, Ellison DH (2006) WNK kinases regulate sodium chloride and potassium transport by the aldosterone-sensitive distal nephron. Kidney Int 70:630-634 (Pubitemid 44215335)
46. Tikhonov DB, Zhorov BS (2009) Structural model for dihydropyridine binding to L-type calcium channels. J Biol Chem 284:19006-19017
47. Triggle DJ (2003) 1,4-dihydropyridine calcium channel ligands: selectivity of action. The roles of pharmacokinetics, state-dependent interactions, channel isoforms, and other factors. Drug Dev Res 58:5-17
48. +2 channels. Trends Pharmacol Sci 12:349-354
49. Tsien RW, Tsien RY, (1990). Calcium channels, stores and oscillations. Annu. Rev. Cell Biol. 6: 715-60. 31
50. Welling A, Ludwig A, Zimmer S, Klugbauer N, Flockerzi V, Hofmann F (1997) Alternatively spliced IS6 segments of the α1C gene determine the tissue-specific dihydropyridine sensitivity of cardiac and vascular smooth muscle L-type Ca2 channels. Circ Res 81:526-532 (Pubitemid 27432739)
51. Yamamoto E, Kataoka K, Dong YF, Nakamura T, Fukuda M, Nako H, Ogawa H, Kim-Mitsuyama S (2010) Benidipine, a dihydropyridine L-type/T-type calcium channel blocker, affords additive benefits for prevention of cardiorenal injury in hypertensive rats. J Hypertens 28:1321
52. Yasuda T, Chen L, Barr W, McRory JE, Lewis RJ, Adams DJ, Zamponi GW (2004) Auxiliary subunit regulation of high-voltage activated calcium channels expressed in mammalian cells. Eur J Neurosci 20:1-13 (Pubitemid 38932122)
53. Zamponi GW, Stotz SC, Staples RJ, Andro TM, Nelson JK, Hulubei V, Blumenfeld A, Natale NR (2003) Unique structure-activity relationship for 4-isoxazolyl-1,4-dihydropyridines. J Med Chem 46:87-96 (Pubitemid 36043788)